Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Azithromycin in Bronchiectasis
NCT02107274Phase 4Completed
- Sponsor
- Hospital Pulau Pinang
- Start
- Nov 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bronchiectasis comparing Azithromycin with Placebo (2 arms). Primary endpoint: 24 Hour Sputum Volume at 24 weeks. Started Nov 2011; status: completed.
02
Drugs
azithromycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT02107274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107274.